For research and educational purposes only. Not medical advice.

Pegvisomant Reference

Educational, not medical advice reference for Pegvisomant: Hormonal; regulatory status, evidence posture, source review, and schedule notes. Als…

Reference summary

Pegvisomant has label-verified evidence in acromegaly. pepSmart surfaces label-reference content only and is not a prescribing tool.

Regulatory and posture

Categories
Hormonal
Aliases
Somavert, GH receptor antagonist
Evidence posture
human
Regulatory status
FDA-approved prescription medication (Somavert). Labeled for acromegaly in adults who have had an inadequate response to surgery and/or radiation therapy, or for whom these therapies are not appropriate. pegvisomant is a GH receptor antagonist, pharmacologically opposite to GH-axis secretagogues.
Content review status
label verified

Selected public sources

Related tools